Stephen K. Doberstein

Insider Reports History

Location
129 Elsie Street, San Francisco, CA
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen K. Doberstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Forte Biosciences, Inc. Director Stock Option (right to buy) 31K Mar 20, 2025 Direct
Dicerna Pharmaceuticals Inc Director Common Stock 0 $38.25 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Director Director Stock Option (Right to Buy) 0 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Director Restricted Stock Units 0 Dec 28, 2021 Direct

Insider Reports Filed by Stephen K. Doberstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FBRX Forte Biosciences, Inc. Mar 20, 2025 1 $0 4 Mar 21, 2025 Director
FBRX Forte Biosciences, Inc. Aug 20, 2024 1 $0 4 Aug 22, 2024 Director
FBRX Forte Biosciences, Inc. Sep 19, 2023 1 $0 4 Sep 20, 2023 Director
FBRX Forte Biosciences, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
FBRX Forte Biosciences, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
FBRX Forte Biosciences, Inc. May 12, 2022 0 $0 3 May 16, 2022 Director
DRNA Dicerna Pharmaceuticals Inc Dec 28, 2021 5 -$127K 4 Dec 29, 2021 Director
DRNA Dicerna Pharmaceuticals Inc Jun 3, 2021 4 $0 4 Jun 7, 2021 Director